R F Johnston, K H Wildrick. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Antitubercular Agents/administration & dosageAntitubercular Agents/therapeutic useAspirin/therapeutic useBCG VaccineBacteriological TechniquesDrug Therapy, CombinationEthambutol/adverse effectsEthambutol/therapeutic useHospitalizationHumansIsoniazid/adverse effectsIsoniazid/therapeutic useLength of StayMycobacterium tuberculosis/isolation & purificationOutpatient Clinics, HospitalPyrazinamide/therapeutic useRifampin/adverse effectsRifampin/therapeutic useStreptomycin/therapeutic useTime FactorsTuberculin TestTuberculosis, Pulmonary/diagnosisTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/microbiologyTuberculosis, Pulmonary/prevention & control
Substances: See more » Antitubercular AgentsBCG VaccinePyrazinamideEthambutolAspirinIsoniazidRifampinStreptomycin
Year: 1974 PMID: 4209115 DOI: 10.1164/arrd.1974.109.6.636
Source DB: PubMed Journal: Am Rev Respir Dis ISSN: 0003-0805